Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Mar-21 | 122.20 | 258.10 | 9.52p | 22.4 | n/a | n/a | 8.65p | 4.0% |
31-Mar-22 | 133.20 | 738.30 | 10.04p | 27.5 | 4.6 | +6% | 9.25p | 3.4% |
31-Mar-23 | 146.70 | (507.50) | 10.30p | 17.0 | 5.7 | +3% | 9.50p | 5.4% |
31-May-24 | 178.10 | 120.00 | 9.32p | 21.9 | n/a | -10% | 11.15p | 5.5% |
31-Mar-25 | 396.70 | 352.80 | 15.73p | 11.7 | 0.2 | +69% | 14.41p | 7.9% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Mar-26 | 390.42 | 343.20 | 13.23p | 14.9 | 15.5 | +1% | 12.34p | 0.0% |
31-Mar-27 | 411.00 | 358.20 | 13.74p | 14.4 | 3.7 | +4% | 12.79p | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
5 Yr High | 5 Yr Low | 5 Yr Avg | Curr / Avg | |
---|---|---|---|---|
Latest | 22.44 | 11.66 | 20.11 | 0.62 |
Find out about IFRS and how this affects the financial infomation for all UK companies.
Currency | UK Pounds |
Share Price | 197.30p |
Change Today | 1.20p |
% Change | 0.61 % |
52 Week High | 209.00 |
52 Week Low | 170.50 |
Volume | 13,453,475 |
Shares Issued | 2,079.46m |
Market Cap | £4,102.78m |
Beta | 0.01 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 5 |
Buy | 2 |
Neutral | 2 |
Sell | 0 |
Strong Sell | 0 |
Total | 9 |
Latest | Previous | |
---|---|---|
4th Interim | 3rd Interim | |
Ex-Div | 29-May-25 | 06-Mar-25 |
Paid | 09-Jul-25 | 11-Apr-25 |
Amount | 3.30p | 3.00p |
Time | Volume / Share Price |
16:49 | 193,681 @ 195.98p |
16:28 | 884 @ 196.70p |
16:28 | 1,055 @ 196.60p |
16:28 | 1,145 @ 196.60p |
16:28 | 2,372 @ 196.60p |
Finance Director | Martin McGann |
CEO | Andrew Jones |
Chair | Alistair Elliott |
You are here: research